Study of Modifications Induced by Continued Direct Oral Anticoagulant Therapy during Atrial Fibrillation Ablation Procedures on Standard Hemostasis Parameters.

Journal of clinical medicine(2023)

引用 0|浏览13
暂无评分
摘要
Our results raise the question of optimal management of intra-procedural heparin therapy and highlight the limitations of the ACT test, particularly in patients on apixaban.
更多
查看译文
关键词
ACT,anti-Xa,atrial fibrillation ablation,direct oral anticoagulant,heparin
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要